0001209191-17-021705.txt : 20170320
0001209191-17-021705.hdr.sgml : 20170320
20170320161444
ACCESSION NUMBER: 0001209191-17-021705
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170316
FILED AS OF DATE: 20170320
DATE AS OF CHANGE: 20170320
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR
CENTRAL INDEX KEY: 0001051997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 17701567
MAIL ADDRESS:
STREET 1: 241-02 NORTHERN BLVD
CITY: DOUGLASTON
STATE: NY
ZIP: 11362
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-16
0
0001000694
NOVAVAX INC
NVAX
0001051997
MCMANUS MICHAEL A JR
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Stock Option (Right to buy)
1.38
2017-03-16
4
A
0
80000
0.00
A
2018-03-16
2027-03-16
Common Stock
80000
80000
D
One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan will vest one (1) year from the March 16, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2017-03-20